Related Experiment Video
Updated: Jun 5, 2026
12:16
Patient Derived Cell Culture and Isolation of CD133+ Putative Cancer Stem Cells from Melanoma
Published on: March 13, 2013
Molecular characterization of putative chordoma cell lines
Silke Brüderlein1, Joshua B Sommer, Paul S Meltzer
1Institute of Pathology, Ulm University, D-89081 Ulm, Germany.
Sarcoma
|January 22, 2011
Summary
This study validates two chordoma cell lines (U-CH1 and U-CH2) for cancer research, identifying and characterizing reliable models for studying chordoma pathogenesis and targeted therapies.
Area of Science:
- Oncology
- Genetics
- Cell Biology
Background:
- Immortal tumor cell lines are crucial for cancer research.
- Cell line misidentification and cross-contamination are significant challenges.
- Existing chordoma cell lines lack detailed characterization.
Purpose of the Study:
- To characterize five putative chordoma cell lines.
- To validate existing cell lines and establish a new one.
- To identify reliable models for chordoma research.
Main Methods:
- Gene expression profiling
- Genomic copy number variation analysis
- Cell line authentication and genotyping
Main Results:
- CCL3, CCL4, and GB60 were identified as non-chordoma cell lines.
- CM319 was identified as a possible chordoma-derived line but lacked key biomarkers.
- U-CH1 and U-CH2 exhibited chordoma-consistent profiles and genetic alterations.
Conclusions:
- U-CH1 and U-CH2 are validated as authentic chordoma cell lines.
- These cell lines serve as valuable models for investigating chordoma pathogenesis.
- The validated cell lines can aid in evaluating novel targeted therapies for chordoma.
